Global Intellectual Property Specialists

Strategic global thinking for the pharmaceutical and biopharmaceutical industries

Our Capabilities

We use our global experience to support life sciences clients from early R&D to commercial launch, and beyond.

Explore our BioBlast®

View our interactive biosimilar news updates, collating tailored reports by brand, INN, originator/biosimilar applicant, litigation, region, or date.

Our People

Our lawyers and attorneys have science backgrounds, were trained at top tier firms, and most have experience in-house at multinational giants.

Award-winning IP services

Ranked internationally and domestically, our pharmaceutical, biopharmaceutical and life sciences focussed lawyers and attorneys are recognised as being among the best IP practitioners in the world.

Our Capabilities

Pearce IP is a boutique firm offering intellectual property specialist lawyers, patent attorneys and trade mark attorneys, to the pharmaceutical, biopharmaceutical and life sciences industries.

With staff based in Australia and New Zealand, we coordinate and execute local and multi-jurisdictional IP litigation strategies, provide IP/legal support for regional and global business development activities and licensing deals, and prosecute patent and trade mark applications around the world.

Patent: Legal and Attorney Services

Trade Mark: Legal and Attorney Services

Commercial IP Services

Regulatory Affairs Services

View our Capabilities

Since its establishment in 2017 boutique Pearce IP has dominated in the area of pharmaceutical patents. Thanks to its deep bench of talented professionals, any life sciences brief is dispatched with alacrity and poise.

IAM Patent 1000, 2024

IP SPECIALIST LAWYERS – PATENT ATTORNEYS – TRADE MARK ATTORNEYS

Our Leaders

Naomi Pearce

CEO, Executive Lawyer (AU, NZ), Patent & Trade Mark Attorney (AU, NZ)

Chris Coates (Maj Ret)

Executive, Finance

Helen Macpherson

Executive, Lawyer (Head of Litigation - Australia)

Kimberley Evans

Executive, Lawyer & Trade Mark Attorney (Head of Trade Marks - Australia)

Dr Mathew Lucas

Executive, Patent & Trade Mark Attorney

Paul Johns

Executive, Lawyer (Head of Litigation - New Zealand)

Julie Ballance

Executive, Patent Attorney and Trade Mark Practitioner (AU, NZ), Lawyer (NZ) & Notary (NZ)

Sally Paterson

Executive, Patent & Trade Mark Attorney (AU, NZ), Lawyer (NZ)

James Tocci

Executive, Corporate Services

Jacinta Flattery-O’Brien PhD

Special Counsel, Patent Attorney

Chantal Savage

Special Counsel, Lawyer

PEARCE IP BLOG

Read our latest updates & insights

Out With The In-Crowd – Gene Therapy For A Previously Excluded, Antibody-Positive Patient Group Ruled Non-Inventive

by Paul Johns, Julie Ballance, Helen Macpherson | Feb 18, 2026

Out With The In-Crowd – Gene Therapy For A Previously Excluded, Antibody-Positive Patient Group Ruled Non-Inventive. The Australian Patent Office has refused to grant a patent on Australian Patent Application 2018299865 in the name of uniQure IP B.V.

Lack Of Clarity Sends Patent Claims Down The Drain – All Valve & Anor V Comino & Anor

by Paul Johns, Helen Macpherson | Feb 18, 2026

Lack of clarity sends patent claims down the drain – All Valve Industries Pty Ltd & Anor V Comino & Anor. In this article, we report on a Federal Court judgment in which Justice Halley determined two proceedings with a number of claims and cross-claims invoking statute, common law and equity.

Pearce IP BioBlast® for the week ending 13 February 2026

by Naomi Pearce, Chantal Savage | Feb 17, 2026

Pearce IP provides weekly reports on global biosimilars activities in the Pearce IP BioBlast®. Significant biosimilar activities for the week ending 13 February 2026 are set out below…